Biomedical technologies in context: Acceptability of a screening tool for sexually transmitted infections and bacterial vaginosis in Zimbabwe and South Africa

= 35). Thematic analysis was guided by Sekhon's framework of acceptability. Women showed a strong desire for devices to support sexual health and viewed diagnostic testing positively. However, acceptability declined when GIFT was explained as a screening tool requiring follow-up diagnostics, due to cost and limited availability of STI tests. HCPs and decision-makers similarly questioned its utility in constrained settings, despite recognising its potential as a potential catalyst for cheaper, point-of-care, infrastructure-light STI diagnostics. GIFT's acceptability is shaped by health system limitations, underscoring the need for clear communication, affordable diagnostics, and co-designed care pathways.

Authors

Institutions

Publication Details

Journal
Global Public Health
Published
2026-04-15
DOI
https://doi.org/10.1080/17441692.2026.2657149
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomedical technologies in context: Acceptability of a screening tool for sexually transmitted infections and bacterial vaginosis in Zimbabwe and South Africa

Chido Dziva Chikwari, Sarah Bernays, Jo‐Ann Passmore, Maureen Tshuma et al.
Global Public Health
Reproductive tract infections research
article

Biomedical technologies in context: Acceptability of a screening tool for sexually transmitted infections and bacterial vaginosis in Zimbabwe and South Africa

Chido Dziva Chikwari, Sarah Bernays, Jo‐Ann Passmore, Maureen Tshuma, Tinashe Mwaturura, Jayjay John Karumazondo, Katherine Gill, Eneyi Kpokiri, Emma Harding-Esch, Jason Naidoo, Thulisa Mayekiso, Constance Ruth Sina Mackworth-Young, Linda Gail-Bekker, Lindi Masson
article en

Abstract

= 35). Thematic analysis was guided by Sekhon's framework of acceptability. Women showed a strong desire for devices to support sexual health and viewed diagnostic testing positively. However, acceptability declined when GIFT was explained as a screening tool requiring follow-up diagnostics, due to cost and limited availability of STI tests. HCPs and decision-makers similarly questioned its utility in constrained settings, despite recognising its potential as a potential catalyst for cheaper, point-of-care, infrastructure-light STI diagnostics. GIFT's acceptability is shaped by health system limitations, underscoring the need for clear communication, affordable diagnostics, and co-designed care pathways.

Global Public HealthVol. 21(1)
Brighton and Sussex Medical School (GB), The University of Sydney (AU), Desmond Tutu HIV Foundation (ZA), University of Zimbabwe (ZW), University of Cape Town (ZA), Stellenbosch University (ZA), Community Medical Center (US), London School of Hygiene & Tropical Medicine (GB), Women's & Children's Health Research Institute (AU), Biomedical Research and Training Institute (ZW), Wellcome Centre for Infectious Diseases Research in Africa (ZA), Monash University (AU)
European and Developing Countries Clinical Trials Partnership
Openalex Percentile: Top 25%
Reproductive tract infections research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.